CAMBRIDGE, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering of an aggregate of 2,604,167 shares of its common stock at a price to the public of $144.00 per share. In addition, Sarepta has granted the underwriters a 30-day option to purchase up to an additional 390,625 shares of its common stock on the same terms and conditions as the initial shares sold to the underwriters. Sarepta anticipates the gross proceeds from the offering, before deducting the underwriter discounts and commissions and other offering expenses, to be approximately $375.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about March 7, 2019, subject to customary closing conditions.
Sarepta Therapeutics Announces Pricing of $375.0 Million Public Offering of Common Stock
Mar 06, 2019
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers